EE360 Decreasing the Economic Impact of Non-Neonatal Circumcision in the Florida Medicaid Population

Abstract

In 2003 Florida Medicaid discontinued coverage of routine neonatal circumcision resulting in an increase in more costly non-neonatal circumcisions. Florida Medicaid will cover a male circumcision in a child > 3 years for a defined medical indication or phimosis refractory to trial of topical steroid therapy (TST). We identified in a prior study that Florida Medicaid spent $1,345,533.90 on non-neonatal circumcisions as opposed to $171,675 if the same 763 boys were circumcised as newborns. Males with Florida Medicaid < 18 years of age with phimosis are referred to surgeons, often without prior management by the primary care provider (PCP).